Testing effectiveness (Phase 2)Study completedNCT04067011What this trial is testingVelocity 2: An Anthrax Vaccine and Antibiotics Clinical StudyWho this might be right forAnthrax Emergent BioSolutions 210
Post-approval studies (Phase 4)WithdrawnNCT03192371What this trial is testingEvaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese ChildrenWho this might be right forVirus Diseases GlaxoSmithKline
Not applicableStudy completedNCT00002287What this trial is testingRetrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the VirusWho this might be right forHIV Infections Glaxo Wellcome
Early research (Phase 1)UnknownNCT03797040What this trial is testingOpen-label Phase I Study for PEP or Treatment of HS-ARS PLX-R18 for the Post-Exposure Prevention (PEP) or Treatment of Hematopoietic Syndrome of Acute Radiation Syndrome (HS-ARS)Who this might be right forIonizing Radiation Exposure Pluristem Ltd. 27
Testing effectiveness (Phase 2)Study completedNCT00949234What this trial is testingInterventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIVWho this might be right forHIV PreventionHIV Infections University of California, Los Angeles 267
Testing effectiveness (Phase 2)Study completedNCT01140880What this trial is testingBiobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With MenWho this might be right forHIV SeroconversionStimulant Abuse Friends Research Institute, Inc. 170
Not applicableUnknownNCT06150937What this trial is testingHST for Female Sex Workers/Drug Users in KazakhstanWho this might be right forHIV TestingIntention City University of New York 90
Post-approval studies (Phase 4)Study completedNCT00385645What this trial is testingAtazanavir or Lopinavir in HIV Post-exposure ProphylaxisWho this might be right forHIV Infections Hospital Clinic of Barcelona 255
Post-approval studies (Phase 4)Active Not RecruitingNCT05986084What this trial is testingTshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in BotswanaWho this might be right forPre-Exposure Prophylaxis (PrEP)Breast Feeding Beth Israel Deaconess Medical Center 500
Post-approval studies (Phase 4)Study completedNCT02198443What this trial is testingComparison of Two Combinations in Antiretroviral Post-Exposure Prophylaxis for HIV-1: Tenofovir/Emtricitabine (Truvada ®) + Lopinavir/Ritonavir (Kaletra ®) vs Tenofovir/Emtricitabine/Cobicistat/Elvitegravir (Stribild ®). Prospective, Randomized, Open.Who this might be right forHIV Fundacion Clinic per a la Recerca Biomédica 160
Post-approval studies (Phase 4)WithdrawnNCT03313414What this trial is testingHCV Post-Exposure Prophylaxis for Health Care WorkersWho this might be right forHepatitis C Massachusetts General Hospital
Not applicableStudy completedNCT05765279What this trial is testingAssess the Efficacy of HH-120 Nasal Spray for Prevention of SARS-CoV-2 Infection in Adult Close Contacts of Individuals Infected With SARS-CoV-2Who this might be right forSARS-CoV-2 Infection Beijing Ditan Hospital 281
Large-scale testing (Phase 3)Study completedNCT01491607What this trial is testingImmunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy AdultsWho this might be right forAnthrax Emergent BioSolutions 200
Large-scale testing (Phase 3)Ended earlyNCT04372017What this trial is testingHydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 InfectionWho this might be right forCOVID-19SARS-CoV 2 Sanford Health 1
Not applicableStudy completedNCT04793750What this trial is testingEnding the HIV Epidemic Through Point-of-Care Technologies (EHPOC)Who this might be right forHIV InfectionsSyphilis Johns Hopkins University 224
Large-scale testing (Phase 3)Looking for participantsNCT05597280What this trial is testingBedaquiline Enhanced Post ExpOsure Prophylaxis for LeprosyWho this might be right forLeprosy Institute of Tropical Medicine, Belgium 124,000
Large-scale testing (Phase 3)Ended earlyNCT04721535What this trial is testingDWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2Who this might be right forCovid19SARS-COV-2 Infection Daewoong Pharmaceutical Co. LTD. 9
Large-scale testing (Phase 3)Study completedNCT06183229What this trial is testingCycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and InfluenzaWho this might be right forInfluenzaAcute Respiratory Infection POLYSAN Scientific & Technological Pharmaceutical Company 166
Post-approval studies (Phase 4)Study completedNCT01781806What this trial is testingA Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention ServicesWho this might be right forHIV Prevention University of California, Los Angeles 328
Not applicableStudy completedNCT04920773What this trial is testingCommunity-based Post-exposure Prophylaxis for COVID-19Who this might be right forCovid19 NMP Medical Research Institute 216